How many patents does
Aptalis Pharmatech have?
patents
614
families
36
granted
155
applications
459
US
93
EP
65
JP
37
CN
35
KR
25
WO
24
RoW
335
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Aptalis Pharmatech
Top ten assignees appearing on patents
2009 - 2018
| aptalis pharmatech | 195 |
| eurand | 122 |
| adare pharmaceuticals | 94 |
| aptalis pharma | 63 |
| eurand pharmaceuticals | 28 |
| allergan | 8 |
| jurand | 2 |
| spin free | 1 |
| eurand pharmaceutical | 1 |
| aptalis pharamtech | 1 |
2009
| eurand | 30 |
| eurand pharmaceuticals | 6 |
2018
| adare pharmaceuticals | 26 |
| aptalis pharma | 5 |
| allergan | 3 |
| eurand pharmaceuticals | 1 |
Aptalis Pharmatech
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| orally administered corticosteroid compositions | 62 | 2009 |
| stable digestive enzyme compositions | 57 | 2007 |
| enteric coated, low-strength pancrelipase formulations | 41 | 2010 |
| orally disintegrating tablet compositions comprising combinations of high and low-dose d… 🛈 | 38 | 2009 |
| preparation of controlled release skeletal muscle relaxant dosage forms | 38 | 2008 |
| pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insu… 🛈 | 35 | 2009 |
| drug delivery systems comprising weakly basic drugs and organic acids | 31 | 2008 |
| orally disintegrating tablet compositions of lamotrigine | 27 | 2007 |
| timed, pulsatile release systems | 25 | 2005 |
| compositions comprising weakly basic drugs and controlled-release dosage forms | 24 | 2008 |